Similar articles

• Mechanistic effects of kijimicin on inhibition of human immunodeficiency virus replication.

  Yamauchi T, Nakamura M, Honma H, Ikeda M, Kawashima K, Ohno T. Yamauchi T, et al. Mol Cell Biochem. 1993 Feb 17;119(1-2):35-41. doi: 10.1007/BF00926851. Mol Cell Biochem. 1993. PMID: 8455584
• GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.

  McGrath MS, Hwang KM, Caldwell SE, Gaston I, Luk KC, Wu P, Ng VL, Crowe S, Daniels J, Marsh J, et al. McGrath MS, et al. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2844-8. doi: 10.1073/pnas.86.8.2844. Proc Natl Acad Sci U S A. 1989. PMID: 2704750 Free PMC article.
• Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.

  De Clercq E. De Clercq E. Biomed Pharmacother. 1996;50(5):207-15. doi: 10.1016/0753-3322(96)87660-8. Biomed Pharmacother. 1996. PMID: 8949401 Review.
• Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase.

  Craig JC, Duncan IB, Hockley D, Grief C, Roberts NA, Mills JS. Craig JC, et al. Antiviral Res. 1991 Dec;16(4):295-305. doi: 10.1016/0166-3542(91)90045-s. Antiviral Res. 1991. PMID: 1810306
• New developments in combination chemotherapy of anti-human immunodeficiency virus drugs.

  Johnson VA, Hirsch MS. Johnson VA, et al. Ann N Y Acad Sci. 1990;616:318-27. doi: 10.1111/j.1749-6632.1990.tb17852.x. Ann N Y Acad Sci. 1990. PMID: 2078026 Review. No abstract available.